SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-065131
Filing Date
2021-05-12
Accepted
2021-05-12 16:16:53
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mrkr-20210331x10q.htm   iXBRL 10-Q 909528
2 EXHIBIT 31.1 mrkr-20210331xex31d1.htm EX-31.1 14770
3 EXHIBIT 31.2 mrkr-20210331xex31d2.htm EX-31.2 14801
4 EXHIBIT 32.1 mrkr-20210331xex32d1.htm EX-32.1 6588
5 EXHIBIT 32.2 mrkr-20210331xex32d2.htm EX-32.2 7371
11 GRAPHIC mrkr-20210331x10q001.jpg GRAPHIC 9753
12 GRAPHIC mrkr-20210331x10q002.jpg GRAPHIC 30571
  Complete submission text file 0001104659-21-065131.txt   3966320

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20210331.xsd EX-101.SCH 34117
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrkr-20210331_cal.xml EX-101.CAL 33777
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrkr-20210331_def.xml EX-101.DEF 61558
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20210331_lab.xml EX-101.LAB 241151
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20210331_pre.xml EX-101.PRE 194397
13 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20210331x10q_htm.xml XML 636263
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 21915323
SIC: 2834 Pharmaceutical Preparations